The
lung cancer therapeutics market
2019-2023, has been added to Technavio's catalog. It provides a comprehensive
analysis of the market, including its global and regional market share as well
as market segmentation based on type and geography for the forecast period
2019-2023.
To learn more about the global trends impacting the future of market
research: Download Free Sample Report
The report on the lung cancer therapeutics market includes:
Lung cancer therapeutics market analysis and forecast 2019-2023:
Features
·
Competitive landscape
·
Market segmentation
o Type
o Geography
·
Market drivers
·
Market trends
·
Market challenges
·
Five forces analysis
·
Market landscape
·
Market sizing & forecast
Lung Cancer Therapeutics Market 2019-2023: Competitive landscape
·
Vendors covered
·
Vendor classification
o Bristol-Myers
Squibb Company
o F. Hoffmann-La
Roche Ltd
o Merck & Co.,
Inc.
o Pfizer Inc.
o Novartis AG
Lung Cancer Therapeutics Market Landscape 2019-2023: Geographic
landscape
·
North America - Market size and forecast 2018-2023
·
Europe - Market size and forecast 2018-2023
·
Asia - Market size and forecast 2018-2023
·
ROW - Market size and forecast 2018-2023
·
Key leading countries
Lung Cancer Therapeutics Market Landscape 2019-2023: Type
·
Non-small-cell lung cancer (NSCLC) - Market size and forecast 2018-2023
·
Small-cell lung cancer (SCLC) - Market size and forecast 2018-2023
Strong prevalence of lung cancer will drive the lung cancer therapeutics
market
Factors such as changes in lifestyle of people and increase in geriatric
population have significantly increased the number of new cancer cases,
especially lung cancer. The highest incidence of lung cancer is found among
African-Americans, followed by Caucasians. Rising incidences of lung cancer is
creating a huge opportunity for the vendors of the market.
Advent of regenerative therapies – An emerging trend in the lung cancer
therapeutics market
Targeted therapies such as immunomodulators do not fully cure lung
cancer indications. This is encouraging various companies to develop
regenerative therapies such as gene therapies through various research and
development activities. Regenerative therapies do not cause any adverse effects
and are in the early stages of development.
Other Key Topics Covered in the Report are:
MARKET LANDSCAPE
·
Market ecosystem
·
Market characteristics
·
Market segmentation analysis
MARKET SIZING
·
Market definition
·
Market sizing 2019
·
Market size and forecast 2019-2023
No comments:
Post a Comment